ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
3D-Printed Metal-Supported MOF-Heteropoly Acid Nanozyme for High-Performance Peroxidase-Mimic Activity and Ultra-Sensitive Glucose Detection.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Benzimidazole-Regulated 1D 4-Fluorosalicylic Acid MOF Composite Material Design and Its Application in Glucose Sensing.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of nanozymes combining high catalytic activity, mechanical robustness, and scalable fabrication is crucial for next-generation biomedical sensing. However, most current 3D-printed diagnostic platforms rely on polymeric substrates that suffer from limited reusability, weak mechanical strength, and poor long-term stability. Here, we report a sustainable and robust nanozyme system based on a 3D-printed Ti-Al─V alloy substrate, chosen for its excellent mechanical integrity, reusability, and intrinsically rough surface that promotes metal-organic framework growth. For the first time, an iron-based MOF (Fe-BTC) is directly grown on a 3D-printed Ti─Al─V substrates with in situ incorporation of phosphomolybdic acid, forming a highly active Fe-BTC-PMA nanozyme. The rough metallic substrates enable uniform MOF nucleation and strong interfacial anchoring, while electronic interactions between the Ti─Al─V substrate and the Fe-BTC-PMA framework facilitate efficient charge transfer and accelerated redox kinetics. Spectroscopic analyses, including XANES, EXAFS, and XPS, reveal PMA-induced modulation of the iron coordination environment and charge redistribution. These results are supported by kinetic studies, in situ electron paramagnetic resonance spectroscopy, and density functional theory calculations. Compared with conventional powder nanozymes, the integrated platform exhibits enhanced catalytic activity, superior stability, and excellent reusability, enabling sensitive and reliable glucose sensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.